• U.S. Food and Drug Administration
    Comprehensive Ophthalmology, Refractive Mgmt/Intervention

    The U.S. FDA has approved the +2.75 D and +3.25 D Tecnis one-piece multifocal IOLs from Abbott Medical Optics.

    Abbott says the new IOLs provide a full range of near, intermediate and distance vision. The +3.25 D IOL is ideal for those who require longer reading distances, such as reading a hand-held device. The +2.75 D IOL is better for those who need better intermediate vision for activities such as reading labels. Abbott also offers a +4.0 D model.

    The approval was based on a study of 445 cataract patients, showing more than 80% of patients could function comfortably without glasses at all distances, and 93% of patients saying they would have the same IOL implanted again. Mean uncorrected visual acuity was 20/25 in both eyes at near distances and 20/20 in both eyes at far distances.